The primary pain point is the manual, time-intensive process of target volume delineation (contouring tumors and organs-at-risk). This step is highly subjective, leading to inter-clinician variability that can compromise treatment efficacy or increase toxicity. Furthermore, generating an optimal radiation dose plan is a complex, iterative trial-and-error process that delays treatment starts and strains limited physics resources, creating a significant capacity bottleneck.
